Prof. Margarida D. Amaral is a mother of 4 sons; in parallel, she has pursued full-time University teaching and research careers being the latter fully dedicated to the basic and translational research of the genetic disease Cystic Fibrosis (CF) for the past 23 yrs. Basic research has its major focus on the molecular and cellular mechanisms of biogenesis, traffic and degradation of normal and mutant membrane protein CFTR (CF transmembrane Conductance Regulator), which when mutated causes CF.
The overall goal of her research is to understand the molecular and cellular mechanisms of CF and to translate this knowledge into the benefit of patients. She has authored 112 international papers (average citations per article: 17.93) 57 of which as senior/corresponding author; 4 book chapters; edited 2 books and 2 special journal issues. Her publications have been cited 2,482 (Scopus) and 3,389 (Google Scholar) times. H-index: 28 (Scopus) 33 (Google Scholar); i10 – index: 74. Researcher ID: E-5748-2012 | Scopus Author (Orchid): ID 7006683774.
Meanwhile, she has been continuously teaching at the University of Lisboa (at the Chemistry and Biochemistry Department) mostly Molecular Biology for 54 semesters with an average teaching of ~9h per week.
She has directly supervised/Co-supervised 15 successfully completed PhD students (+6 ongoing); 16 post-doctoral fellows (+4 ongoing); and more than 23 junior students (BSc + MSc). I also mentor(ed) 4 independent (FCT) researchers and 1 Assistant Professor.
She has participated 31 grants, 18 of which as Principal Investigator, amounting to~3.6M€. Seven of these were from EU, of which she coordinated one (TargetScreen2) and Vice-coordinated another (EuroCareCF).
She is an EMBO member since 2014. Currently, she is Director of BioISI- Biosystems & Integrative Sciences Institute (Lisboa, Portugal), coordinator of PhD programme BioSys (funded by FCT) and member of the Scientific Advisory Board (SAB) of the European Cystic Fibrosis Society (ECFS) being coordinator of ECFS Basic Science Working Group and Associate Editor of Journal of Cystic Fibrosis (Elsevier). She is a former SAB member of and CF Trust (UK) and Mukoviszidose e.V (German CF Foundation).
She has registered 3 patents and she regularly develops business consulting activities with industry (BioMarin; Vertex; Facilitate; Gilead; LEK; Reuters; Novartis etc).
She gave 135 invited international talks (+36 national), including one opening plenary of North-American Cystic Fibrosis Conference (2007) and 4 opening plenaries at European CF Society Conferences (2004, 2008, 2013, 2016). She organized and for 10 years the ECFS-Basic Science conferences and 6 international training workshops for young researchers in the CF field. In total, she organized 26 international conferences, being President of 2013 ECFS-European CF
Qualifications: MD, MRCPCH, FESC
Present Position: Senior Consultant Pediatric Cardiologist and Director of Paediatric Cardiology, Hospital Santa Cruz, Lisbon, Portugal
Previous Positions: Pediatric and Pediatric Cardiology training at Santa Maria University Hospital, Lisbon; Fellowships at Brompton, Guy´s and Harefield Hospitals, Consultant Pediatric Cardiologist, Santa Maria University Hospital, 1991-93, Staff Pediatric Cardiologist, New Orleans Children's Hospital and Associate, Professor of Pediatrics, LSUMC, 1993-1994, Visiting Pediatric Cardiologist, Texas Children's Hospital, 1994
Academic Positions: Histology and Embryology Lecturer, 1978-82 and Biology Lecturer, 1987-88, School of Medical Sciences, Lisbon, Associate Professor of Pediatrics, Louisiana State University, New Orleans, 1993-94, Honorary Lecturer in Pediatrics, Lisbon Medical School, 2015-present
Scientific papers and Conferences Publications: Over 300 communications as author / co-author in scientific meetings, 80 lectures and conferences in scientific meetings,110 papers published in peer reviewed journals; 15 book chapters; Editor, Portuguese Pediatric Formulary (3 editions)
Other activities: President of the Portuguese Pediatric Cardiology Society, 2007-2010. Council Member and Treasurer, Interventional Working Group of Association for European Pediatric Cardiology, 2010-2013
Dr Paul Aurora, Consultant in Paediatric Respiratory Medicine and Lung Transplantation, Great Ormond Street Hospital for Children Honorary Senior Lecturer, UCL Institute of Child Health has been a consultant at GOS since 2002, where he primarily works in tertiary paediatric respiratory medicine, but also has additional duties in lung transplantation, and some duties in cardiac transplantation. He is academic lead for respiratory medicine at GOS, and clinical lead for paediatric respiratory physiology. He helped set up the International Pediatric Lung Transplant Collaboration, and until 2010 was Assistant Director of the Registry of the International Society for Heart and Lung Transplantation. He was the paediatric co-chair of the 2008-2012 ATS/ISHLT/ERS working group for diagnosis and management of bronchiolitis obliterans syndrome in lung transplant recipients; was involved with a joint ERS/ATS working group to establish standards for lung function testing in preschool children, chairing the spirometry section; and was chair of the ERS Scientific Group on Paediatric Respiratory Physiology. He was chair of the ERS Paediatric Long Range Planning Committee until late 2016. In 2002 he received the European Respiratory Society Award for Pediatric Research in Europe.
Prof. Andrew Bush is the Professor of Paediatrics and Head of Section (Paediatrics), Imperial College, Professor of Paediatric Respirology, National Heart and Lung Institute, and Consultant Paediatric Chest Physician, Royal Brompton Hospital, London UK. He is also Editor in Chief of Thorax, with Professor Ian Pavord.
His main research interests are the invasive and non-invasive assessment of airway inflammation, paediatric clinical physiology, and orphan lung diseases.
Associate Professor Catherine (Cass) Byrnes MBChB, FRACP, GCCE, MD is an Associate Professor in the Paediatric Department at the University of Auckland and a Paediatric Respiratory Specialist at the Starship Children’s Hospital, Auckland, New Zealand. She completed her medical training in New Zealand, neonatal training at John Radcliffe Hospital Oxford and respiratory specialist training at the Royal Brompton Hospital & National Heart and Lung Institute in London where she completed her MD thesis. In her University role, she leads a research programme focused on improving outcomes of early childhood infection, recurrent pneumonias, bronchiectasis and cystic fibrosis - especially improving care of indigenous children - with 8 international collaborations and findings translated to changes in medical care. She was the Director of Undergraduate Medical School Paediatric Teaching for 6 years and is currently the Director of the FRACP paediatric programme in NZ. At Starship Children’s Hospital, she developed new national services (outreach, fibreoptic bronchoscopy, bronchiectasis, home ventilation/oxygen) and continues to lead bronchiectasis and cystic fibrosis care. She is the Chair of the PORT CF registry development and is on the editorial board of the New Zealand Formulary for Children.
Malena Cohen Cymberknoh, M.D, was born in Buenos Aires, Argentina, in 1973. She graduated from the University of Buenos Aires in 2000 and immigrated as a medical doctor to Israel at the same year. She is married and a mother of four children. Dr. Cohen-Cymberknoh did her residency in Pediatrics and her fellowship in Pediatric Pulmonology at the Hadassah-Hebrew University Medical Center in Jerusalem, finishing the specialization on February 2010. Since then she has worked as a senior physician in the Pediatric Department and in the Center for Chronic Diseases in Childhood at Hadassah. Additionally, she is a senior lecturer and the responsible for Pediatrics for 6th year medical students, at the Hebrew University Medical School, in Jerusalem. Her special research interest fields include Cystic fibrosis (CF), Primary Ciliary Dyskinesia (PCD), asthma and other chronic lung disease (e.g. interstitial lung disease). Dr. Cohen-Cymberknoh is involved in CF research as co-investigator of many national and international multi-center clinical trials. She is also very involved in international collaborations and teaching CF teams all over the world (e.g., Argentina, Uruguay, Chile Russia and Gaza strip).
Her scientific publications include a number of papers published in some of the highest accredited journals e.g. American Journal of Respiratory Critical Care Medicine, Chest, PlosOne, European Respiratory Journal, Pediatric Pulmonology, and Journal of Cystic Fibrosis.
Andrew Colin, MD is the Batchelor Professor of Cystic Fibrosis and Pediatric Pulmonology and Chief of the Division of Pediatric Pulmonology, Miller School of Medicine of the University of Miami. He has continually held leadership positions with the International Congresses of Pediatric Pulmonology (CIPP) and served as the President of its 10th and 11th Congresses.
Dr. Colin published extensively and presented nationally and internationally in areas of his interest: structural and functional development and morbidity of the respiratory system with related physiological measurements, including lung diseases of late prematurity, infants with CF and HIV. Pediatric bronchoscopy. Infectious and inflammatory diseases of the lung. Pediatric Radiology.
Jorge Correia-Pinto, MD, PhD (47 years-old, married, father of two kids; Chief of Pediatric Surgery at Hospital of Braga, and Full Professor at School of Medicine, University of Minho) is the Coordinator of the Surgical Sciences Research Domain at the Life and Health Sciences Research Institute (ICVS) and Director of the Pediatric Surgical Department of Hospital de Braga. His research main interests are cardio-pulmonary physiology in pulmonary hypertension conditions (ie, congenital diaphragmatic hernia), and minimally invasive surgical (MIS) techniques. During the last 15 years, he constituted a research team with MDs, biologists and engineering that progressively acquired expertise in several techniques to modulate and assess gene expression, which are used in vivo and ex vivo experimental models of pulmonary hypoplasia and hypertension to evaluate the role of specific pathways with potential therapeutic applicability. Given his interest in MIS techniques, he encouraged a group to develop efforts to launch an operative lab for animals (pigs and rabbits) for training and teaching. Currently, the Endoscopic Research Lab provides more than 20 hands-on courses in minimally invasive surgery per year and trains over 500 surgeons a year.
Jorge Correia-Pinto has published in PubMed over one hundred and fifty peer-reviewed research articles (mean IF: 4.5, which had been cited by more than 2000 other papers; h index-22). He has supervised 14 PhD and currently supervises another 4 PhD students. He has received several awards and honors for his research achievements and serves as an Ad hoc reviewer for various pediatric, physiology and surgical journals.
Adnan Custovic is Clinical Professor of Paediatric Allergy at Imperial College London. His research has focused upon the origins and natural history of asthma and allergy across the life-course, with an emphasis on prevention and translation for patient benefit. His research findings are of great practical significance, and have informed and changed national and international guidelines on asthma prevention/management. His current research programme combines world-leading expertise in birth cohorts and statistical machine learning, and capitalises on the recent developments within the field of computer sciences to provide powerful new tools that are well suited to the challenge of integration of different scales of data (from molecular-level to population-level), and different levels of directness of measurement of factors.
In 2015 Prof Custovic was awarded the highly competitive European Respiratory Society Gold Medal for research in asthma. In 2013 he received the BSACI William Frankland Medal for outstanding contributions to clinical allergy, and the CIPP President’s award for the distinguished achievements in childhood asthma. He delivered numerous prestigious keynote/named lectures, including Nemacolin Asthma Conference (2014), Alain De Weck Memorial Lecture (2013), Cas Motala Memorial Lecture (South African Allergy Society, 2013), James Hutchison's Memorial Lecture (Hong Kong Paediatric Society, 2012), the RSM Priscilla Piper Lecture (2011) and Caspar Weinberg Lecture (2007).
He has served as a Secretary of the BSACI for two terms, and as President of Asthma section of the EAACI.
Renato Cutrera, MD, PhD, graduated in Medicine at the University of Rome La Sapienza in 1981, and obtained the board in pediatrics and in respiratory diseases in 1985 and 1994, respectively.
He is, since 2000, head of the Pediatric Pulmonology Unit, Respiratory Intermediate Care Unit, Sleep and PLTVU at the Pediatric Hospital “Bambino Gesù” in Rome. The main fields of his clinical activity concern severe asthma, acute, chronic and congenital respiratory disorders in children and adolescents, non-invasive mechanical ventilation, in particular for children with severe neuromuscular diseases, Congenital Central Hypoventilation Syndrome and other rare respiratory conditions in children.
Dr Cutrera is author of over 100 scientific articles in various fields of research on pediatric disorders
Prof Jane Davis has 20 years’ experience in paediatric respiratory research, the focus of which have been a) the development of new treatments and trial outcome measures for CF, b) pseudomonal infection and c) airway wall inflammation and remodelling. She is currently national or global Lead Investigator on 8 NIHR-adopted, commercially sponsored, multicentre clinical trials of novel CF therapies. She has supervised 21 higher degrees to completion for which she was awarded the Imperial College President & Rector’s Gold Medal in 2012. Their students have gone on into senior university, tertiary and secondary medicine posts. Over the last 10 years, she has raised over £21 million in external grant funding, published over 80 peer-reviewed primary research papers, 50 review articles, contributed 14 chapters to textbooks and edited 5 textbooks. She regularly reviews papers for all the respiratory journals and is Associate Editor of Thorax, the respiratory journal with the third highest impact factor. She is Chair of the Research Committee for the British Paediatric Respiratory Society; sit on the British Thoracic Committees for Science & Research and Training; the Strategic Implementation Board of the CF Trust and the European CF Society Conference Board. From 2007-2010 she sat on the Royal Brompton & Harefield Foundation Trust’s Research Ethics Committee. She is closely involved in a number of institutional PPEI activities and engage regularly with two PPI representatives supporting her own research programme.
Pr Brigitte Fauroux is professor in pediatrics and head of a pediatric noninvasive ventilation and sleep unit and a respiratory physiology laboratory in Necker university hospital in Paris, France. She is a pediatric pulmonologist and her main interests are sleep-disordered breathing, noninvasive ventilation, chronic respiratory insufficiency, the evaluation of the work of breathing and respiratory muscle capacity in a wide range of pediatric disorders. She has published more than 230 international papers.
Thomas Ferkol, M.D. is the Alexis Hartmann Professor of Pediatrics, Professor of Cell Biology and Physiology at Washington University School of Medicine (St. Louis, Missouri), and past President of the American Thoracic Society.
Dr. Ferkol received his medical degree from the Ohio State University College of Medicine. He was pediatric resident, chief resident, and clinical instructor at the University of North Carolina at Chapel Hill. Dr. Ferkol completed his fellowship training in pediatric pulmonology at Case Western Reserve University, where he subsequently joined the pediatric faculty. Dr. Ferkol moved to Washington University School of Medicine sixteen years ago, and is Director of the Division of Pediatric Allergy, Immunology, and Pulmonary Medicine.
An American Lung Association Edward Livingston Trudeau Scholar and recipient of the Cystic Fibrosis Foundation LeRoy Matthew’s Physician-Scientist Award, Dr. Ferkol’s research has focused on the development of cell and animal models to study cystic fibrosis and primary ciliary dyskinesia, defining genetic and molecular factors that contribute to chronic airway infection, inflammation, and epithelial injury with almost twenty-five years of funding from the National Institutes of Health (NIH). More recently, Dr. Ferkol and his collaborators have been involved in the development and application of noninvasive imaging and physiological measurements to assess lung development and predict respiratory outcomes in chronic lung diseases related to prematurity. He has authored over 140 original articles, scholarly reviews, and book chapters.
Ricardo M Fernandes, MD, PhD is I an attending pediatrician, assistant professor and clinical researcher. His research background includes clinical epidemiology, clinical trial methodology, clinimetrics and synthesis research, with training and fellowships in the Netherlands and Canada. His main clinical research interests are pediatric respiratory disease, allergy and emergency medicine, in particular bronchiolitis, wheezing and asthma, and his favored methodological topics include research on outcomes and measurement, clinical trial design, meta-analysis, knowledge translation, and clinical pharmacology, particularly in pediatrics.
He has been actively involved in a number of international research collaborations, including the StaR Child Health initiative on improving clinical trial research in pediatrics, the PERN (Pediatric Emergency Research Networks) worldwide academic clinical research network and the COMET initiative (Core Outcome Measures in Effectiveness Trials. He is particularly engaged in several activities within the Cochrane Collaboration, being a Co-Director of the Cochrane Child Health Field.
Some of the current research projects he is involved with in the field of pediatric respiratory medicine include, among others, the development of a core outcome set for future bronchiolitis trials (with the University of Liverpool), knowledge synthesis and network meta-analysis in bronchiolitis (with the Alberta Research Center for Health Evidence), and activities with the European Respiratory Society, including chairing a Task Fore on the definition and selection of outcomes in bronchiolitis, and participating in a clinical research collaboration on severe asthma.
Rosário Ferreira, MD, MSc, Consultant in Paediatrics, Sleep specialist, working in a tertiary Pediatric Respiratory Unit.
Head of the Pediatric Sleep Lab of the Pediatric Department, Santa Maria Hospital, Lisbon.
Assistant of Paediatrics, Lisbon Medical School, Lisbon University. Board member of the Portuguese Pediatric Pulmonology Society.
Special interests are Pediatric sleep disorders, chronic domiciliary ventilation, long term oxygen therapy, asthma and medical education.
Author of several publications and talks on the main interest areas. Clinical research on sleep disorders.
Dr Louise Fleming is a Clinical Senior Lecturer in Respiratory Paediatrics at the National Heart and Lung Institute and Consultant Respiratory Paediatrician at the Royal Brompton Hospital with a clinical and research interest in children with problematic asthma.
Dr Fleming’s research interests include distinguishing difficult from severe therapy resistant asthma, phenotyping severe asthma, interventions for problematic severe asthma and the use of biomarkers in asthma and pre school wheeze. She is the clinical lead for asthma at the Royal Brompton where she has developed the difficult asthma protocol and the National Registry for children with difficult asthma. She is a member of the BTS Specialist Advisory Group for Severe Asthma, a member of the BTS/SIGN clinical guidelines group and Chair of the Asthma UK Health Professionals Council.
Matthias Griese, MD. Pediatrician, Pulmonologist, Allergologist, Neontologist; Director Pediatric Pneumology and Cystic Fibrosis.
Professor of Pediatrics, Childrens´ Hospital, University of Munich. Special interest in rare parenchmy lung diseases and surfactant disorders.
Research fellow B. Braun Foundation; Postdoc Pediatrics, Yale University, New Haven, USA.
John Henderson is Professor of Paediatric Respiratory Medicine at the University of Bristol and Bristol Royal Hospital for Children, UK. He graduated from the University of Manchester and after training in paediatrics, he was a research fellow in Bristol, UK and Perth, Western Australia. He was awarded his MD by the University of Manchester in 1991. He returned to complete his training in paediatric respiratory and critical care medicine and was appointed as a consultant in paediatric respiratory medicine in 1993.
John’s main research interests are in the epidemiology of asthma and respiratory health in early life. He joined the Avon Longitudinal Study of Parents and Children in 1995. He is now Co-Director of ALSPAC and leads the respiratory and allergy programme. He has published over 150 papers and co-edited the Respiratory Disorders chapter in Forfar & Arneil’s Textbook of Pediatrics. He was formerly Deputy Editor of Archives of Disease of Childhood.
Prof. Eitan Kerem, MD, a world known leader in Cystic Fibrosis research, is a principal investigator of numerous national and international multicenter clinical trials. He is the author of seminal publications in the field, including phenotype-genotype relationships, disease prognostic factors, the molecular mechanisms for disease variability, and the development of novel mutation-specific pharmacological therapies to correct the basic defects in cystic fibrosis.
His many interests extend beyond cystic fibrosis, and he has been central to studies examining environmental interactions with genetic diseases and its influence on the disease severity, genetic markers of asthma and allergy in closed populations, and variability of disease in closed populations exposed to different environments. Increasingly, his efforts have turned to understanding the genetics of primary ciliary dyskinesia in Jewish and Palestinian children. In addition he published leading papers on management of community acquired pneumonia in children and was the first to characterize nectrotizing pneumonia and risk factors for complicated pneumonia in children.
The promotion of the medical, ethical and rights aspects of children with chronic diseases is at the forefront of his interest. He published many papers in this field and is known for his advocacy for children in need.
He also has a record of building bridges between Israelis and Palestinians furthering peace through medicine wherever possible.
Professor Kerem received a number of prestigious awards the last being the European CF Society Award in 2014.
He has authored over 170 papers covering all aspects of Pulmonology.
Prof. Amir Kugelman is a Clinical Associate Professor of Pediatrics in The R&B Rappaport Faculty of Medicine, Technion, Haifa, Israel. He specialized in Pediatric Pulmonology and Neonatology in Children's Hospital, LA, CA, and is currently the Director of the Pediatric Pulmonary Unit and a Senior Neonatologist in Bnai Zion Medical Center, Haifa, Israel and the Chairman of the Israeli Society of Pediatric Pulmonology.
His main research is in Neonatal Pulmonology, focusing on non- invasive ventilation, non-invasive respiratory monitoring in the NICU and the Pediatric Department, and in the prevention and treatment of Choric Lung Disease of premature infants. Other areas of interest and research: Iatrogenesis in NICUs, late preterm infants, outcome of VLBW infants, and delayed cord clamping in the delivery room.
Dr. Fernando D. Martinez is a Regents’ Professor and Director of the Asthma and Airway Disease Research Center at the University of Arizona in Tucson.
Dr. Martinez is a world-renowned expert, and one of the most highly regarded researchers, in the field of childhood asthma. His primary research interests are the natural history, genetics, and treatment of childhood asthma.
His groundbreaking research has had an impact on his field in numerous ways, most prominent among them the development of the concept of the early origins of asthma and COPD. This concept is now widely accepted as the potential basis for the design of new strategies for the prevention of these devastating illnesses affecting millions of children and adults worldwide. In addition, Dr. Martinez has made important contributions to our understanding of the role of gene-environment interactions in the development of asthma and allergies. He has also been the principal investigator of one of the Clinical Centers that are part of the NHLBI Asthma Treatment Networks, which have contributed fundamental new evidence on which to base national guidelines for the treatment of the disease.
Dr. Martinez currently serves on national scientific boards including the NHLBI National Advisory Council and the National Scientific Council on the Developing Child. He was a member of the National Asthma Education and Prevention Program that was responsible for the development of the Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma in 1997 and its first revision in 2001. He also has been a member of the FDA Pulmonary-Allergy Drugs Advisory Committee and the Board of Extramural Advisors of the National Heart, Lung, and Blood Institute (NHLBI).
Dr. Martinez’s research and vision are well detailed in more than 250 original research papers and editorials, many in collaboration with investigators from all over the world. He is frequently invited to give keynote presentations at national and international meetings.
Dr. Paulo Pitrez completed his undergraduate degree in Medicine at the Federal University of Rio Grande do Sul (UFRGS, 1993) in Brazil, and obtained his Ph.D. in Medicine (Pulmonology) at UFRGS (2001). Dr. Pitrez is a pediatric pulmonologist and completed his clinical and research training at the Princess Margaret Hospital for Children and the University of Western Australia (Perth, Australia) in 2000. He is currently a full Professor of the School of Medicine at the Pontifical Catholic University of Rio Grande do Sul (PUCRS), Director of the Institute of Biomedical Research (PUCRS), and reviewer of international peer-review journals (European Respiratory Journal, Pediatric Allergy and Immunology, Pediatric Pulmonology, Brazilian Journal of Pediatrics, Brazilian Journal of Pulmonology, and Clinics). Dr. Pitrez's research interests include severe asthma in children, novel therapies for asthma, immune response in asthma, and education of patients, working in clinical studies and experimental models. He is a researcher officially sponsored by the Research Brazilian Agency (CNPq), with more than 400 citations in the Scopus, with h-factor of 13.
Prof. Petr Pohunek, MD PhD FCCP. Head, Division of Pediatric Respiratory Diseases, Pediatric Department, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
Chairman of the Czech Society for Pediatric Pulmonology.
Chairman, Group 7.7 (Pediatric Bronchology) of the Pediatric Assembly of the European Respiratory Society.
Main research interest: Pediatric Asthma; Primary ciliary dyskinesia; Pediatric chronic respiratory diseases.
Dr. Fernando Polack is a Specialist in Pediatric Infectious Diseases, graduated with Honors from the University of Buenos Aires in 1990. Dr. Polack completed residency training at the French Hospital in Buenos Aires and at William Beaumont Hospital in Michigan followed by a post-doctoral fellowship at Johns Hopkins University. Dr. Polack is the Cesar Milstein Professor in the Department of Pediatrics at Vanderbilt University and the Scientific Director of the INFANT Foundation in Buenos Aires which coordinates a network of 26 hospitals in Argentina. Dr. Polack has led numerous scientific manuscripts in reputed journals, including N Eng J Med, Nature Med, J Exp Med and PNAS, among others. His work is funded by the Bill & Melinda Gates Foundation, the National Institutes of Health, the Thrasher Research Fund, the Optimus Foundation and other international organizations.
Dr Martí Pons is consultant paediatrician for pediatric intensive care in Hospital Sant Joan de Déu, one of the largest paediatric teaching hospitals in Spain. He is also in charge of the Home ventilation program.
Graduated from Medical School at Barcelona University in 1990,Martí did his PhD research in the same university, and defended his thesis about “non-invasive ventilation in the acute setting” cum laude. He was trained in Paediatrics and did his fellowship in Paediatric Intensive Care at Hospital Sant Joan de Deú were exerts his current position as a consultant.
Dr. Pons’s clinical interests include respiratory care in critical care. Active areas of research include mechanical ventilation, mainly focused on non invasive ventilation (NIV). Martí has contributed to more than 40 articles in peer-reviewed journals, and has edited three books on paediatric non-invasive ventilation. Recently has launched, the third edition written in collaboration with Dr Medina, Martinón-Torres, Gili and Mayordomo-Colunga.
Dr. Pons is member of Respiratory working group of Spanish PICU society and ESPNIC (European society). Last eight years has participated in many international meetings and organized several courses promoting NIV use in acute and also chronic pediatric patient.
Prof. Jean-Paul Praud is a Senior Pediatric Pulmonologist at the Sherbrooke University Hospital, Quebec, Canada, and Director, Center for Research into Maternal and Child Health, University of Sherbrooke. He holds the Canada Research Chair in Neonatal Respiratory Physiology.
He is Past-President, CIPP V and has been President, ICPP-The Course, since 2007.
His main research interests are in the field of sleep apneas, nasal ventilation and laryngeal function.
Prof. Giovanni A. Rossi
1990 - Present: Chief, Pulmonary and Allergy Units, G. Gaslini Institute, Genoa, Italy.
1992 - Present: Adjunct Professor of Paediatric Pulmonology, University of Genoa, Italy.
1980 - Present: Member of the American Thoracic Society.
1992 - 1994: Chairman of the Assembly "Lung Cell Biology" of the European Respiratory Society.
1992 - 1994: Member of the Executive Committee of the European Respiratory Society.
1999 - 2005: Assessor of the Interasma Executive Committee
2007 - 2011: President Italian Society of Paediatric Respiratory Disorders.
1985 - 1987: Associate Editor, "Bulletin Europeen de Physiopathologiae Respiratoire".
1986 - 1992: Section Editor for Immunology & Lung Cells, of "The European Respiratory Journal".
1991 - Present: Charter Member of the Board of Reviewing Editors of the "Journal of Laboratory and Clinical Medicine".
1992 - 2004: Member of the Editorial Board, "Paediatric Pulmonology".
1992 - 2005: Member of the Editorial Board, "Monaldi, Archives for Chest Diseases".
2004 - Present: Member of the editorial board of "Current Pediatric Reviews."
2004 - Present: Member of the editorial board of “Current Respiratory Medicine Reviews."
2007 - 2010: Section Editor of “Respiratory Medicine”
Major research interests:
Publications: 1 book, 14 book chapters and 283 manuscripts (pubmed).
Prof. Bruce Rubin is the Jessie Ball duPont Distinguished Professor and Chair of Pediatrics at Virginia Commonwealth University in Richmond, Virginia and Physician in Chief of the Children’s Hospital of Richmond. He is also Professor of Biomedical Engineering and Adjunct Professor of Physiology and Biophysics at VCU. Prof Rubin is a pediatric pulmonary physician and a Fellow of the Royal Society of Physicians of Canada (FRCPC). As a Rhodes Scholar, he trained as a post doc in Biomedical Engineering at Oxford University and in Paediatric Respirology at Sick Kids in Toronto. He holds the MD and Masters in Engineering degrees from Tulane and an MBA degree from Wake Forest University School of Business.
Dr. Rubin received the 2008 Forrest M. Bird Lifetime Scientific Achievement Award, the top research honor given by the American Association for Respiratory Care (AARC), in 2011 he presented the Phil Kittredge Memorial Keynote lecture at the AARC in 2012, he was awarded Jimmy Young Memorial medal from the AARC. He holds honorary appointments in 4 medical schools. He is on the editorial board of 12 medical journals, has published more than 200 original research papers and chapters and holds seven patents. Dr. Rubin and his research team study aerosol therapy for lung diseases, airway inflammation and excessive mucus that contributes to lung disease.
He is also an accomplished magician, an elected member of the International Brotherhood of Magicians, and over the past 20 years had taught medical magic in 28 countries on 5 continents.
Sejal Saglani is Reader in Paediatric Respiratory Medicine at the National Heart & Lung Institute, Imperial College London and Honorary Consultant in Respiratory Paediatrics, Royal Brompton Hospital, London.
The focus of her research includes: 1) mechanisms underlying the development of wheezing disorders in preschool children and factors that determine progression to childhood asthma, and management of preschool wheezing using inflammatory and infective airway phenotypes. 2) Diagnosis and management of paediatric severe therapy resistant asthma and mechanisms mediating the pathophysiology of severe disease to determine novel therapeutic targets.
She runs a translational research programme incorporating a neonatal murine model of inhaled allergen exposure and bronchoscopic airway samples from children with severe wheezing and asthma.
Luiz Vicente Ribeiro Ferreira da Silva Filho, MD, PhD, is a Pediatrician specialized in Pediatric Pulmonology. He was graduated in the Medical School of Universidade de São Paulo in 1990, did his fellowship and Pediatric Pulmonology specialization at Instituto da Criança HCFMUSP, had a MSc title obtained in 1998, and a PhD in 2002, both in the area of Medicine. His main interests are related to cystic fibrosis, respiratory infections and molecular-based diagnostic methods. He is an assistant doctor at Instituto da Criança HCFMUSP, working with fellowship training, assistance to outpatients and inpatients, as well as clinical research. He is also a pediatric pulmonology specialist at Hospital Israelita Albert Einstein, and acts currently as a full professor of Post-Graduate programs at Universidade de São Paulo and at Hospital Israelita Albert Einstein, in São Paulo, Brazil. He is also the Executive Coordinator of the Brazilian Cystic Fibrosis Patient Registry since its foundation, in 2009, and is currently leading the initiative of the Brazilian Cystic Fibrosis Diagnosis and Treatment Guidelines.
Dr. Manuel E. Soto-Martínez is an Assistant Professor of Paediatrics and Paediatric Pulmonology, School of Medicine of the University of Costa Rica. Graduated in Paediatrics from the University of Costa Rica in 2007. From 2007 to 2010 he completed his fellowship in respiratory medicine at the Royal Children´s Hospital in Melbourne, Victoria, Australia. In addition, he completed his Masters in Epidemiology at the National University of Costa Rica (2013-2015). He is currently a Paediatric Respiratory Physician and Sleep Physician at the Respiratory Department, Hospital Nacional de Niños, San José, Costa Rica.
His areas of expertise/research:
- - Paediatric Ashtma: severe asthma, asthma epidemiology
- - Respiratory infections
- - Paediatric bronchoscopy
- - Cystic Fibrosis
- - Non-Invasive ventilation, home oxygen
- - Respiratory related Sleep Disturbances
- - Respiratory Complications in Neuromuscular disease
- - Member of the American Thoracic Society
- - Member of the European Respiratory Society
- - Member of Asociación Latinoamericana de Tórax (ALAT)
- - Member of Asociación Costarricense de Tórax
- - Consultant in Respiratory Medicine, Hospital Nacional de Niños, San José, Costa Rica
- - Coordinator Home Ventilation Program, Hospital Nacional de Niños, San José, Costa Rica.
- - A/Prof. Pediatrics, School of Medicine, Universidad de Costa Rica
- - Member of the Postgraduate in Paediatrics’ Academic Committee, Universidad de Costa Rica
Renato T. Stein, MD, MPH, PhD graduated in Medicine in 1979 from Pontifícia Universidade Católica, in Porto Alegre, Brazil where he completed his residency in Pediatrics in 1982. He took over as Assistant Professor at the Department of Pediatrics in 1986, and from 1987 to 1989 was a fellow in the Pediatric Pulmonary Service in Toronto, at The Hospital for Sick Children. In 1994 Dr. Stein took a position as a research fellow in Tucson, Arizona, where he worked with the Children’s Respiratory Study cohort, publishing in the field of risk factors related to asthma in children. In 2011 he did a 6 months sabaticcal in the Center for Environmental Epidemiology, in Barcelona, Spain. In Brazil Dr. Stein has been leading a large and productive group of researchers at his Institution. His main areas of interest are the relation between respiratory viruses and recurrent wheeze, asthma phenotypes, impact of the environment on respiratory health, and respiratory disease of preterm infants.
Alexander Ocampo Tuazon, MD, MDE. Philippine Board certified in Pediatrics and Pediatric Pulmonology, active in teaching, research and clinical practice. A holder of a Master in Distance Education. Professor in Pediatrics, past Director of the Institute of Child Health and Human Development, University of the Philippines Manila. Current Head, Section of Pediatric Pulmonology at the College of Medicine, University of the Philippines Manila, Vice President of the Philippine Pediatric Society and Member of the Philippine Subspecialty Board in Pediatric Pulmonology. Research interests include asthma, pulmonary infections and pulmonary physiology. Has published with book chapters, consensus statements on asthma, and research articles both in the Philippines and in international publications. An officer and member in a number of professional organizations involved in pediatrics, pediatric pulmonology, asthma, pharmacology, and pharmaceutical medicine. Contact Address: Section of Pulmonology, Department of Pediatrics, Philippine General Hospital, Taft Avenue, Manila, Philippines.
Prof. Stijn Verhulst, MD, PhD is professor in pediatrics at the University of Antwerp, Belgium and head of the pediatric pulmonoly and sleep unit at the Antwerp University Hospital. He is also director of the Antwerp Cystic Fibrosis Center and consultant at Inkendaal Hospital, Belgium. His research mainly focuses on the complications and management of sleep-disordered breathing in children. He was co-chair of a European Respiratory Society Task force on obstructive sleep apnea in children. More recently, he started several new research projects in non-invasive ventilation, BPD and cystic fibrosis. He is author or co-author of more than 90 papers and book chapters in national and international journals.
Erika von Mutius is Professor of Pediatrics and holds a degree in Epidemiology from Harvard School of Public Health, USA. She is head of the Asthma and Allergy Clinics at the Dr von Hauner Children’s Hospital of Ludwig-Maximilians-University Munich and the Munich University Asthma and Allergy Research Group (www.asthma-allergy.de). Professor von Mutius’ working group has been actively involved in design, implementation and data analysis of many large, Pan-European multicenter and interdisciplinary projects, including birth cohort studies, addressing the role of genetic and environmental, particularly microbial factors for the development of asthma and allergic diseases.
Professor Gary Wong obtained his undergraduate medical education from the University of Alberta, Canada. He subsequently received fellowship training at University of British Columbia, and Children’s Hospital of British Columbia, Canada and a visiting Fellowship at the Children’s Hospital at Munich, Germany. He then returned to Hong Kong to teach at the Chinese University of Hong Kong.
Dr Wong’s main research interests include different aspects of allergic and respiratory diseases. In particular, he is interested in the epidemiology and environmental determinants of asthma, wheezing illness, related allergic disorders, non-invasive monitoring of asthma, assessment of asthma control, and respiratory infections. He is currently a member of the board of directors of the Global Initiative for Asthma (GINA) and he is one of the steering committee members of the ISAAC (International Study of Asthma and Allergies in Childhood) research group. He has published over 200 original articles, review papers, and book chapters in the field of asthma and allergies. He is the current President of the Asia-Pacific Association of Pediatric Allergy, Respirology and Immunology (APAPARI). Among other duties within several editorial boards, he is also an associate editor of New England Journal of Medicine, one of the Section Editors of Pediatric Allergy and Immunology and the Associate Editor of Pediatric Pulmonology.
Heather Zar is Professor and Chair of the Department of Paediatrics and Child Health, Director of the School of Child and Adolescent Health at Red Cross Childrens Hospital at the University of Cape Town (UCT), South Africa. After specialising in Paediatrics she did a fellowship in Paediatric Pulmonology, then a PhD. She is based at Red Cross Childrens Hospital, one of the largest dedicated childrens’ hospital in Africa. She leads a large department in providing care for sick children, training of undergraduate and post graduate students, undertaking research and advocacy to promote child health. Her work on childhood respiratory diseases, including tuberculosis, pneumonia, asthma and HIV-associated lung diseases has been internationally recognized; she has published more than 200 peer reviewed publications and has substantial international grant support. She has established a strong training program in childhood lung diseases including training several paediatricians in Africa. She currently serves as President of the Pan African Thoracic Society and President of the Forum of International Respiratory Societies. She received the World Lung Health award in 2014.